Claims
- 1. A medicinal composition comprising (1) a compound represented by the following formula (I) or substantially water-insoluble anthelmintic analogues thereof as an active ingredient ##STR2## and (2) at least two nonionic surfactants, in a total amount of not less than 1 part by weight per part by weight of said compound (I).
- 2. A medicinal composition according to claim 1, wherein the nonionic surfactants are selected from glcyerol fatty acid esters, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene glycerol fatty acid esters, polyoxyethylene hydrogenated castor oil, lecithin derivatives, polyoxyethylene sorbitol fatty acid esters, polyoxyethylene glycol fatty acid esters, polyoxyethylene castor oil, polyoxyethylene alkyl ethers, polyoxyethylene polyoxypropylene alkyl ethers, polyoxyethylene lanolin, polyoxyethylene lanolin alcohol, propylene glycol fatty acid esters and polyglycerol fatty acid esters.
- 3. A medicinal composition according to claim 1, wherein the composition contains at least one compound selected from fats and oils.
- 4. A medicinal composition according to claim 3, wherein the fats and oils are selected from almond oil, olive oil, sesame oil, safflower oil, soybean oil, corn oil, rape seed oil, castor oil, cotton seed oil, beef tallow and hardened oils.
- 5. A medicinal composition according to claim 1, wherein the composition contains at least one compound selected from aqueous solvents.
- 6. A method of treating a parasitic infection which comprises administering to animals or humans suffering from a parasitic infection the medicinal composition according to claim 1, wherein the medicinal composition is administered orally, intravenously, subcutaneously or intradermally.
- 7. A medicinal composition comprising (1) a compound represented by the following formula (I) or substantially water-insoluble anthelmintic analogues thereof as an active ingredient ##STR3## and (2) at least one nonionic surfactant, (3) one or more aqueous solvents, and (4) one or more fats and oils, wherein the total amount of the ingredients (2), (3) and (4) is at least 1 part by weight per part by weight of said compound (I).
- 8. A medicinal composition according to claim 7, wherein the nonionic surfactant is selected from glcyerol fatty acid esters, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene glycerol fatty acid esters, polyoxyethylene hydrogenated castor oil, lecithin derivatives, polyoxyethylene sorbitol fatty acid esters, polyoxyethylene glycol fatty acid esters, polyoxyethylene castor oil, polyoxyethylene alkyl ethers, polyoxyethylene polyoxypropylene alkyl ethers, polyoxyethylene lanolin, polyoxyethylene lanolin alcohol, propylene glycol fatty acid esters and polyglycerol fatty acid esters.
- 9. A medicinal composition according to claim 7, wherein the fats and oils are selected from almond oil, olive oil, sesame oil, safflower oil, soybean oil, corn oil, rape seed oil, castor oil, cotton seed oil, beef tallow and hydrogenated oils.
- 10. A medicinal composition according to claim 7, wherein the aqueous solvents are selected from ethylene glycol, propylene glycol, polyethylene glycol, glycerol and N-methyl-2-pyrrolidone.
- 11. A method of treating a parasitic infection which comprises administering to animals or humans suffering from a parasitic infection the medicinal composition according to claim 7, wherein the medicinal composition is administered orally, intravenously, subcutaneously or intradermally.
Priority Claims (1)
Number |
Date |
Country |
Kind |
3-043461 |
Mar 1991 |
JPX |
|
Parent Case Info
This is a continuation of application Ser. No. 07/846,076 filed Mar. 5, 1992, now abandoned .
Foreign Referenced Citations (1)
Number |
Date |
Country |
0179583 |
Apr 1986 |
EPX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
846076 |
Mar 1992 |
|